Welcome to LookChem.com Sign In|Join Free

CAS

  • or

55410-21-4

55410-21-4

Post Buying Request

55410-21-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

55410-21-4 Usage

Uses

Ethyl alfa-amino butyrate, HCl

Check Digit Verification of cas no

The CAS Registry Mumber 55410-21-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,4,1 and 0 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 55410-21:
(7*5)+(6*5)+(5*4)+(4*1)+(3*0)+(2*2)+(1*1)=94
94 % 10 = 4
So 55410-21-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO2.ClH/c1-3-5(7)6(8)9-4-2;/h5H,3-4,7H2,1-2H3;1H

55410-21-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name ETHYL ALFA-AMINO BUTYRATE

1.2 Other means of identification

Product number -
Other names (+/-)-2-amino butyric acid ethyl ester hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:55410-21-4 SDS

55410-21-4Relevant articles and documents

BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS

-

Paragraph 0408-0411, (2021/06/11)

The invention relates to certain 1,5-benzothiazepine and 1,2,5-benzothiadiazepine derivatives as defined herein. These compounds are bile acid modulators having apical sodium-dependent bile acid transporter (ASBT) and/or liver bile acid transport (LBAT) inhibitory activity. The invention also relates to pharmaceutical compositions comprising these compounds and to the use of these compounds in the treatment of cardiovascular diseases, fatty acid metabolism and glucose utilization disorders, gastrointestinal diseases and liver diseases.

A facile synthesis of multigram quantity of ethyl 3-ethylmorpholine-3- carboxylate

Jagodzinski, Jacek J.,Aubele, Danielle L.,Quincy, David A.,Dappen, Michael S.,Latimer, Lee H.,Hom, Roy K.,Galemmo Jr., Robert A.,Konradi, Andrei W.,Sham, Hing L.

supporting information; experimental part, p. 2471 - 2472 (2011/05/16)

A five-step synthesis of ethyl 3-ethylmorpholine-3-carboxylate proceeding from readily available 2-aminobutyric acid is detailed herein.

Hypolipidemic 1,4-benzothiazepine-1,1-dioxides

-

, (2008/06/13)

The invention is concerned with novel hypolipidemic compounds of formula (I), with processes and novel intermedites for their preparation, pharmaceutical compositions containing them and with their use in medicine, particularly in the prophylaxis and treatment of hyperlipidemic conditions, such as atherosclerosis. STR1

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 55410-21-4